Dr. PIYUSH KOHLI

Dr. RENU PUTHENVILAYIL RAJAN, Dr. K. NARESH BABU, Dr.Aditya Maitray

Abstract

This retrospective study included 17 patients (mean age, 49.4±8.6 years). 6 patients did not have prior history of CML. 3 patients had HbA1C ≥8 g/dL. 28 eyes (82.4%) presented with visual loss. Mean presenting BCVA was logMAR 0.90±0.86 (SE, 20/159). All eyes presented with proliferative retinopathy. The presenting clinical features included VH (26.5%), TRD (23.5%), ME (26.5%), NVG (11.8%) and hyphaema (5.9%).

Treatment included PRP 64.7%), anti-VEGF IVI (35.3%) and vitrectomy (38.2%). Retina was attached in 91.2% patients at last FU (mean FU, 14.5±13.0 months). Final BCVA was logMAR 0.72±0.81 (SE, 20/105). Final BCVA was ≥20/60 in 17 eyes (50.0%) and <20/200 in ten eyes (29.4%). 3 eyes underwent cycloablation. IOP was controlled in all the patients. Patients with co-existing DM and CML present with advanced retinopathy, which tends to progress rapidly. An aggressive ocular and systemic treatment, and a closer follow-up is warranted for such patients. The final outcome is poor

Full Text